Peter J. Fromen
Algemeen Directeur bij Biomodal Ltd.
Actieve functies van Peter J. Fromen
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Biomodal Ltd.
 Biomodal Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom. | Directeur/Bestuurslid | 18-07-2022 | - |
| Algemeen Directeur | 18-07-2022 | - |
Loopbaan van Peter J. Fromen
Eerdere bekende functies van Peter J. Fromen
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Corporate Officer/Principal | 08-01-2021 | 20-05-2022 |
| ILLUMINA, INC. | Investor Relations Contact | 03-06-2011 | - |
| Public Communications Contact | 01-01-2007 | 24-05-2011 | |
| Corporate Officer/Principal | - | - | |
| Verkoop & Marketing | 24-05-2011 | 03-06-2011 |
Opleiding van Peter J. Fromen
| Kenyon College | Undergraduate Degree |
| W.P. Carey School of Business | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 5 |
| Verenigd Koninkrijk | 2 |
Operationeel
| Corporate Officer/Principal | 2 |
| Investor Relations Contact | 1 |
| Public Communications Contact | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ILLUMINA, INC. | Health Technology |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Biomodal Ltd.
Biomodal Ltd. Miscellaneous Commercial ServicesCommercial Services Cambridge Epigenetix Ltd. provides epigenetic tools. Its TrueMethyl oxidative bisulfite sequencing, a novel technology that pioneers single-base resolution sequencing of the modified bases hydroxymethyl cytosine and methylcytosine. The firm's TrueMethyl enables analysis of the DNA methylome offers basic research, pharmaceutical discovery and diagnostics and TrueMethyl can be used with methylation arrays and targeted assays. The company was founded by Shankar Balasubramanian, Michael Booth and Bobby Yerramilli-Rao in 2012 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
- Beurs
- Insiders
- Peter J. Fromen
- Ervaring
